Why the study?
Do different hormonal contraceptives alter free TFPI and free PS levels in users of contraceptives?
Do different hormonal contraceptives alter free TFPI and free PS levels in users of contraceptives?
The effect of oral contraceptives on free TFPI and free PS levels provides a possible biological explanation for the acquired APC resistance and increased risk of venous thrombosis associated with their use.
Answers are grounded in this paper and cite their sources.
No data on contraceptive effects on TFPI/PS levels; leaves open their link to APC resistance and VTE risk.
Use of combined oral contraceptives is associated with a three- to six-fold increased risk of venous thrombosis. Hormonal contraceptives induce acquired resistance to activated protein C (APC), which predicts the risk of venous thrombosis. The biological basis of the acquired APC resistance is unknown. Free protein S (PS) and free tissue factor pathway inhibitor (TFPI) are the two main determinants of APC. Our objective was to assess the effect of both hormonal and non-hormonal contraceptives with different routes of administration on free TFPI and free PS levels. We conducted an observational study in 243 users of different contraceptives and measured APC sensitivity ratios (nAPCsr), free TFPI and free PS levels. Users of contraceptives with the highest risk of venous thrombosis as reported in recent literature, had the lowest free TFPI and free PS levels, and vice versa, women who used contraceptives with the lowest risk of venous thrombosis had the highest free TFPI and free PS levels. An association was observed between levels of free TFPI and nAPCsr, and between free PS and nAPCsr. The effect of oral contraceptives on TFPI and PS is a possible explanation for the increased risk of venous thrombosis associated with oral contraceptives.
No takes yet. Share an insight, caveat, or question.
Helmerhorst et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: